Acute coronary syndromes and percutaneous coronary interventions: Impact of bleeding and blood transfusion

Hamostaseologie

Volumn 29, Issue 4, 2009, Pages 381-387

  Bassand, Jean Pierre ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Acute coronary syndrome; Percutaneous coronary intervention

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; NITRIC OXIDE;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; HEART INFARCTION; HUMAN; INFLAMMATION; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STROKE;

EID: 70549092883     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617129     Document Type: Review

References (64)

1. Rao SV, Eikelboom JA, Granger CB et al. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1193-1204. (Pubitemid 47343833)
2. Eikelboom JW, Mehta SR, Anand SS et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774-782. (Pubitemid 44268228)
3. Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. Jama 2004; 292: 1555-1562. (Pubitemid 39314961)
4. Rao SV, O'Grady K, Pieper KS et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005; 96: 1200-1206. (Pubitemid 41505393)
5. Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660.
6. Bassand JP. Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm. Heart 2008; 94: 661-666. (Pubitemid 351580149)
7. Rao SV, O'Grady K, Pieper KS et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 809-816. (Pubitemid 43243106)
8. Moscucci M, Fox KA, Cannon CP et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
9. Doyle BJ, Ting HH, Bell MR et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17 901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv 2008; 1: 202-209.
10. Feit F, Voeltz MD, Attubato MJ et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007; 100: 1364-1369. (Pubitemid 47576015)
11. Jani SM, Smith DE, Share D et al. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention. Clin Cardiol 2007; 30 (10 Suppl 2): II49-56. (Pubitemid 47587499)
12. Kim P, Dixon S, Eisenbrey AB et al. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol 2007; 30 (10 Suppl 2): II35-43. (Pubitemid 47587497)
13. Kinnaird TD, Stabile E, Mintz GS et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003; 92: 930-935. (Pubitemid 37214804)
14. Ndrepepa G, Berger PB, Mehilli J et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008; 51: 690-697. (Pubitemid 351221218)
15. Fox KA, Dabbous OH, Goldberg RJ et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006; 333: 1091.
16. Meneveau N, Schiele F, Seronde MF et al. Anemia for risk assessment of patients with acute coronary syndromes. Am Heart Cardiol 2009; 103: 442-447.
17. Voeltz MD, Patel AD, Feit F et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007; 99: 1513-1517. (Pubitemid 46770636)
18. Dauerman HL, Lessard D, Yarzebski J et al. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 2005; 96: 1379-1383. (Pubitemid 41566617)
19. Alexander KP, Chen AY, Roe MT et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. Jama 2005; 294: 3108-3116. (Pubitemid 43016802)
20. Granger CB, Goldberg RJ, Dabbous O et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2453. (Pubitemid 37310196)
21. Eagle KA, Lim MJ, Dabbous OH et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post-discharge death in an international registry. Jama 2004; 291: 2727-2733. (Pubitemid 38725422)
22. Mehta SK, Frutkin AD, Lindsey JB et al. Bleeding patients undergoing percutaneous coronary intervention: The development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Intervent 2009; 2: 222-229.
23. Nikolsky E, Mehran R, Dangas G et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007; 28: 1936-1945. (Pubitemid 47579535)
24. Subherwal S, Alexander K. Crusade Bleeding Risk Score. http://www.crusadebleedingscore.org/ (accessed 2 July 2009).
25. Joyner CD, Peters RJ, Afzal R et al. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J 2009; 157: 502-508.
26. Budaj A, Eikelboom JW, Mehta SR et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2009; 30: 655-661.
27. Spencer FA, Moscucci M, Granger CB et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007; 116: 2793-2801.
28. Manoukian SV, Feit F, Mehran R et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007; 49: 1362-1368. (Pubitemid 46476844)
29. Spiess BD. Blood transfusion: the silent epidemic. Ann Thorac Surg 2001; 72: S1832-S1837.
30. Spiess BD. Blood transfusion for cardiopulmonary bypass: the need to answer a basic question. J Cardio thorac Vasc Anesth 2002; 16: 535-538.
31. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8: 267-281.
32. Spiess BD. Risks of transfusion: outcome focus. Transfusion 2004; 44: 4S-14S.
33. Spiess BD. Choose one: damned if you do/damned if you don't! Crit Care Med 2005; 33: 1871-1874.
34. Rawn JD. Blood transfusion in cardiac surgery: a silent epidemic revisited. Circulation 2007; 116: 2523-2524. (Pubitemid 350182386)
35. Yang X, Alexander KP, Chen AY et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46: 1490-1495. (Pubitemid 41446184)
36. Rao SV, Chiswell K, Sun JL et al. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2008; 101: 25-29. (Pubitemid 350297192)
37. Alexander KP, Chen AY, Wang TY et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 2008; 155: 1047-1053.
38. Yatskar L, Selzer F, Feit F et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007; 69: 961-966.
39. Chase AJ, Fretz EB, Warburton WP et al. Association of the arterial access site at angioplasty with transfusion and mortality: the MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008; 94: 1019-1025.
40. Murphy GJ, Reeves BC, Rogers CA et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-2552.
41. Hill SR, Carless PA, Henry DA et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002: CD002042.
42. Koch CG, Li L, Sessler DI et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
43. Hebert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
44. Hebert PC, Yetisir E, Martin C et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-234.
45. Bennett-Guerrero E, Veldman TH, Doctor A et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104: 17063-17068. (Pubitemid 350210992)
46. Berezina TL, Zaets SB, Morgan C et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002; 102: 6-12. (Pubitemid 34941245)
47. Raat NJ, Verhoeven AJ, Mik EG et al. The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model. Crit Care Med 2005; 33: 39-45; 238-239.
48. Sparrow RL, Veale MF, Healey G et al. Red blood cell (RBC) age at collection and storage influences RBC membrane-associated carbohydrates and lectin binding. Transfusion 2007; 47: 966-968. (Pubitemid 46802083)
49. Allen BW, Piantadosi CA. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol 2006; 291: H1507-H1512. (Pubitemid 44497652)
50. Crawford JH, Isbell TS, Huang Z et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006; 107: 566-574. (Pubitemid 43076380)
51. Reynolds JD, Ahearn GS, Angelo M et al. S-Nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci USA 2007; 104: 17058-17062. (Pubitemid 350210991)
52. Fransen E, Maessen J, Dentener M et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-1239. (Pubitemid 29535973)
53. Janatpour K, Holland PV. Noninfectious serious hazards of transfusion. Curr Hematol Rep 2002; 1: 149-155.
54. Netzer G, Shah CV, Iwashyna TJ et al. Association of RBC transfusion with mortality in patients with acute lung injury. Chest 2007; 132: 1116-1123. (Pubitemid 47620982)
55. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006; 21: 167-174.
56. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002; 16: 304-314.
57. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-348.
58. Yusuf S, Mehta SR, Chrolavicius S et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 354: 1464-1476.
59. Stone GW, Witzenbichler B, Guagliumi G et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218-2230. (Pubitemid 351724451)
60. Collet JP, Montalescot G, Agnelli G et al. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. Eur Heart J 2005; 26: 2285-2293. (Pubitemid 41541393)
61. Agostoni P, Biondi-Zoccai GG, de Benedictis ML et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004; 44: 349-356. (Pubitemid 38950594)
62. O'Connell KA, Wood JJ, Wise RP et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. Jama 2006; 295: 293-298. (Pubitemid 43112957)
63. Samama CM, Djoudi R, Lecompte T et al. Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth 2005; 52: 30-37.
64. Cannon CP, Husted S, Harrington RA et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol 2007; 50: 1844-1851. (Pubitemid 350007959)